يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Stein EA"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging study.

    المؤلفون: Ballantyne CM, Miller M, Niesor EJ, Burgess T, Kallend D, Stein EA

    المصدر: American Heart Journal; Mar2012, Vol. 163 Issue 3, p515-521.e3, 1p

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

    المؤلفون: Ballantyne CM; Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, TX, USA. cmb@bcm.tmc.edu, Bertolami M, Hernandez Garcia HR, Nul D, Stein EA, Theroux P, Weiss R, Cain VA, Raichlen JS

    المصدر: American heart journal [Am Heart J] 2006 May; Vol. 151 (5), pp. 975.e1-9.

    نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

    بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

    مواضيع طبية MeSH: Apolipoproteins B/*blood , Cholesterol/*blood , Cholesterol, LDL/*blood , Coronary Disease/*prevention & control , Fluorobenzenes/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use , Sulfonamides/*therapeutic use, Aged ; Atorvastatin ; Coronary Disease/etiology ; Dose-Response Relationship, Drug ; Female ; Fluorobenzenes/adverse effects ; Heptanoic Acids/administration & dosage ; Heptanoic Acids/adverse effects ; Heptanoic Acids/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Male ; Middle Aged ; Pyrimidines/adverse effects ; Pyrroles/administration & dosage ; Pyrroles/adverse effects ; Pyrroles/therapeutic use ; Risk Factors ; Rosuvastatin Calcium ; Simvastatin/administration & dosage ; Simvastatin/adverse effects ; Simvastatin/therapeutic use ; Sulfonamides/adverse effects ; Treatment Outcome

    View record from ScienceDirect Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء